| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $312.5M | -22.3% |
| Cost of Revenue | $93.4M | -34.6% |
| R&D Expense | $99.9M | -19.9% |
| SG&A Expense | $80.0M | -12.7% |
| Operating Income | -$183.2M | -64.5% |
| Interest Expense | $14.5M | +196.7% |
| Income Tax | $2.7M | -34.3% |
| Net Income | -$134.3M | -33.7% |
| EPS (Basic) | -$1.51 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $183.2M | -13.1% |
| Accounts Receivable | $28.7M | -64.9% |
| Current Assets | $231.2M | -28.1% |
| Total Assets | $607.8M | -27.3% |
| Current Liabilities | $139.9M | -47.7% |
| Total Liabilities | $675.1M | -14.3% |
| Stockholders' Equity | -$67.3M | -239.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.1M | +23.5% |
| Capital Expenditures | $25.1M | -12.3% |
| Investing Cash Flow | -$28.2M | -49.8% |
| Financing Cash Flow | $15.0M | +109.9% |
| Free Cash Flow | -$40.3M | +16.8% |
| -18.0% |
| EPS (Diluted) | -$1.51 | -18.0% |